Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current programs include:
More disciplines coming soon……
Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions
You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
NEW Psychiatry. Patients with schizophrenia want the same things we want in life, they want to return back to life, having a sense of purpose, being able to have their symptoms improve, where they can go back to having relationships with those around them. How can we achieve this post-discharge from hospital?
Prof. Greg Mattingly, Psychiatrist & Psychopharmacologist, St Louis, MissouriNEW Psychiatry. In this interview we speak with Prof. Roger McIntyre, named as one of ‘The World’s Most Influential Scientific Minds’! We discuss the heterogeneous nature of depression and how to minimise residual symptoms, such as tiredness or the inability to concentrate when treating depression.
Prof. Roger McIntyre, Professor of Psychiatry and Pharmacology, University of Toronto, CanadaNEW Neurology. How can we fill the gap between available therapies and more advanced technologies used to treat Parkinson’s? In this interview we discuss how to manage patients experiencing unpredictable off periods out in the community, as well as the involvement of movement disorder clinics and the necessary assistance and infrastructure.
David Tsui, Clinical Nurse Consultant in Parkinson’s Disease & Movement Disorders, Westmead Hospital, SydneyNEW Neurology. Where do we go when patients continue to have symptoms? In this interview we discuss the practicalities of continuous infusions, intestinal gels and deep brain stimulation, including key considerations when deciding between them and the need for early identification and education.
A/Prof. John O’Sullivan, Visiting Neurologist, The Movement Disorders Service, Royal Brisbane & Women’s HospitalNEW Respiratory. When you are seeing patients with asthma and airway disease in your clinical practice, if those patients are either; having frequent exacerbations or on maximum dose therapy, ask yourself, could this person have severe refractory eosinophilic asthma, and if so, could they benefit from one of the biologics? We review results from new long-term data that supports their use in clinical practice.
Prof. Peter Gibson, University of Newcastle, Hunter Medical Research Institute, John Hunter Hospital, NewcastleNEW Respiratory. As respiratory physicians we need to be across the latest information available, especially for patients with difficult to treat or severe asthma, the types of patients that are often referred to us for specialist assessment and management. This is where GINA, the Global Initiative for Asthma, comes in. In this interview we talk through the new GINA pocket guide in relation to strategies to treat severe asthma.
Prof. Helen Reddel, Respiratory Physician, & Research Leader, the Woolcock Institute of Medical Research, University of SydneyNEW Respiratory. In terms of difficult asthma, we’re in very exciting times! We now have the opportunity to substantially minimise exposure of patients to oral corticosteroids to try and minimise the burden of illness. In this interview we discuss identifying patients that would benefit from a reduction in oral corticosteroids, tips on down-titrating oral corticosteroids and starting patients on biologic agents.
Prof. Peter Wark, Senior Staff Specialist, Respiratory & Sleep Medicine, John Hunter Hospital, Newcastle & Conjoint Professor, University of NewcastleNEW Respiratory. There are now three biologic agents for severe refractory asthma available in Australia. These agents when chosen appropriately can improve asthma control and decrease the risk of exacerbations. We need to ensure that these therapies are given to the right sort of patient, so what factors do we need to consider?
Prof Paul Thomas, Respiratory & Sleep Medicine Physician, SydneyNEW Neurology. Making a diagnosis of epilepsy can be difficult, particularly establishing the difference between focal and generalised seizures, and this differential is critical. In this interview we discuss this, as well as how to ensure the patient gets the right treatment, early on.
A/Prof. Wendyl D’Souza, Epileptologist, St Vincent’s Hospital, MelbourneNEW Neurology. One of the most difficult areas of practice for neurologists are the rules and regulations around driving with epilepsy. There’s a lot of confusion and immense interest in this topic, so in this interview we discuss the social consequences and the practical issues.
Prof. Ernest Somerville, Neurologist, Sydney, Chair of Australian & New Zealand Association of Neurologists’ Driving Committee
Tap the share icon 
and select 'Add to Home Screen' to add the site to your home screen for quick access!